Background:  Statins are traditionally used in lowering cholesterol and low-density lipoprotein biosynthesis, but recent reports show their beneficial effect on microcirculation. The aim of this study was to investigate the effect of simvastatin on the microcirculation and in conjunction with aspirin in a rat free epigastric flap model.

Methods:  Thirty-six Sprague-Dawley rats were divided into group A (control,  = 12), group B (simvastatin treated,  = 12), and group C (simvastatin and aspirin,  = 12). Bilateral free epigastric skin flap was used to evaluate the effect. At 48 hours, flaps biopsies were evaluated for inflammatory activity, nitric oxide content, and thrombomodulin regulation in the endothelial lining of microvessels. Flap survival was evaluated on day 7.

Results:  The diameter of microvessels and nitric oxide activity in groups B and C were significantly higher than in group A ( < 0.005 and 0.015, respectively). The perivascular inflammatory cell infiltrates and intravascular adhesions were predominant in group A compared with groups B and C ( < 0.005). Groups B and C demonstrated significant higher degree of thrombomodulin expression. The flap survival rate on day 7 was 70.8% for group A, and 87.5% and 91.7%, respectively, for groups B and C without significance between the two ( = 0.675).

Conclusion:  Simvastatin significantly improves the free flap survival by effective anti-inflammatory, vasodilator, and anticoagulant activities. Combined therapy did not have an antagonistic effect and further study is needed to see synergistic action through different mechanisms.

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0039-1701030DOI Listing

Publication Analysis

Top Keywords

free epigastric
8
 = 12 group
8
group simvastatin
8
nitric oxide
8
simvastatin
4
simvastatin free
4
free tissue
4
tissue transfer
4
transfer experimental
4
experimental study
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!